Research map: Additional value of 10-min far-delayed phase in extracellular contrast agent-enhanced MRI for diagnostic performance of hepatocellular carcinoma based on LI-RADS v2018

Back to the article

Papers in this map

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries · Hyuna Sung · 2021 · 114646 citations · Cited by this paper
  2. Neonatal hepatic elastography for assessment of intestinal failure–associated liver disease: a feasibility study and review of literature · 2024 · Related
  3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma · Peter R. Galle · 2018 · 11646 citations · Cited by this paper
  4. The study of altered brain structure in preterm infants with low grade intraventricular hemorrhage utilizing 3D T1WI whole brain MR images · 2026 · Related
  5. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases · Jorge A. Marrero · 2018 · 4682 citations · Cited by this paper
  6. Preoperative prediction of pathologic response to neoadjuvant immunotherapy in resectable locally advanced head and neck squamous cell carcinoma using multiparametric MRI · 2024 · Related
  7. Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME · Agostino Colli · 2006 · 540 citations · Cited by this paper
  8. Ultrasound measurements of renal internal structures in patients with chronic kidney disease · 2024 · Related
  9. CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features · Jin‐Young Choi · 2014 · 532 citations · Cited by this paper
  10. Feasibility of gate myocardial perfusion scintigraphy in patients with multivessel coronary artery disease: clinical case · 2026 · Related
  11. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma · So Yeon Kim · 2016 · 357 citations · Cited by this paper
  12. Ultrasound identification of the semitendinosus raphe: a key landmark to differentiate it from the semimembranosus muscle · 2025 · Related
  13. Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging · Katsuhiro Sano · 2011 · 355 citations · Cited by this paper
  14. Chinese expert consensus on magnetic resonance enterography of the small intestine and standardized reporting guidelines: translation · 2024 · Related
  15. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic Review · Christian B. van der Pol · 2018 · 333 citations · Cited by this paper
  16. Recent advances in magnetic resonance imaging using metal-organic frameworks · 2025 · Related
  17. Hepatocellular Carcinoma with a Pseudocapsule on Gadolinium-enhanced MR Images: Correlation with Histopathologic Findings · Kousei Ishigami · 2008 · 193 citations · Cited by this paper
  18. Evaluation of hippocampal volumes with MRI in Alzheimer’s disease · 2025 · Related
  19. Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI · Jordi Rimola · 2012 · 185 citations · Cited by this paper
  20. Apparent diffusion coefficients of resectable rectal adenocarcinoma and distal paracancerous tissues derived from diffusion weighted imaging: association with tumor stage · 2026 · Related
  21. LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid–enhanced MRI · Sang Hyun Choi · 2018 · 174 citations · Cited by this paper
  22. Detection of Hepatocellular Carcinoma: Value of Adding Delayed Phase Imaging to Dual-Phase Helical CT · Jae Hoon Lim · 2002 · 124 citations · Cited by this paper
  23. Dynamic CT for Detecting Small Hepatocellular Carcinoma: Usefulness of Delayed Phase Imaging · Shuichi Monzawa · 2006 · 115 citations · Cited by this paper
  24. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases · Theodora A. Potretzke · 2016 · 112 citations · Cited by this paper
  25. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs · Anita Paisant · 2019 · 80 citations · Cited by this paper
  26. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance · Toshifumi Gabata · 1998 · 73 citations · Cited by this paper
  27. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout · Alessandro Furlan · 2011 · 72 citations · Cited by this paper
  28. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging · Seo‐Youn Choi · 2018 · 71 citations · Cited by this paper
  29. Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis · Chansik An · 2017 · 69 citations · Cited by this paper
  30. Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging. · Mary T. Keogan · 1997 · 59 citations · Cited by this paper
  31. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine · Marco Dioguardi Burgio · 2016 · 51 citations · Cited by this paper
  32. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma · Jennifer Sammon · 2018 · 50 citations · Cited by this paper
  33. Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum · Ji Hye Min · 2017 · 47 citations · Cited by this paper
  34. Effect of Gd‐EOB‐DTPA on T2‐weighted and diffusion‐weighted images for the diagnosis of hepatocellular carcinoma · Kazuhiro Saito · 2010 · 44 citations · Cited by this paper
  35. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI · Ji Yoon Moon · 2021 · 30 citations · Cited by this paper
  36. Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI · Jiyoung Hwang · 2017 · 28 citations · Cited by this paper
  37. Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR‐M : Comparison with Those Categorized as LR ‐4 or 5 · Jaeseung Shin · 2021 · 28 citations · Cited by this paper
  38. Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category · H.J. Park · 2020 · 23 citations · Cited by this paper
  39. Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent · Roberto Cannella · 2021 · 21 citations · Cited by this paper

Source: OpenAlex (CC0)